livemint.com
71%
329
J&J vaccine candidate prevents severe COVID-19 in hamsters: Study
COVID-19 vaccine candidate, co-developed by the American multinational company Johnson and Johnson, raises neutralising antibodies that robustly protect hamsters against severe infection with the novel coronavirus, according to a study.The research, published in the journal Nature Medicine, demonstrated that the vaccine elicited robust immune response in Syrian golden hamsters, and prevented severe clinical disease including weight loss, pneumonia, and death.The vaccine, co-developed by the Beth Israel Deaconess Medical Center and Johnson & Johnson (J&J), uses a common cold virus, called adenovirus serotype 26 (Ad26), to deliver the SARS-CoV-2 spike protein into host cells, where it stimulates the body to raise immune responses against the